APA (7th ed.) Citation

F, H., MHED, M., MA, A., HA, A., HA, A., AA, A., & BAA, N. (2026). Reprogramming resistance in advanced lung cancer: Epigenetic modulation to restore therapeutic vulnerability. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico. https://doi.org/10.1007/s12094-026-04316-6

Chicago Style (17th ed.) Citation

F, He, Moawad MHED, Alsaied MA, Abdul-Hafez HA, Alhadrami HA, Azhari AA, and Nawas BAA. "Reprogramming Resistance in Advanced Lung Cancer: Epigenetic Modulation to Restore Therapeutic Vulnerability." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 2026. https://doi.org/10.1007/s12094-026-04316-6.

MLA (9th ed.) Citation

F, He, et al. "Reprogramming Resistance in Advanced Lung Cancer: Epigenetic Modulation to Restore Therapeutic Vulnerability." Clinical & Translational Oncology : Official Publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2026, https://doi.org/10.1007/s12094-026-04316-6.